Amilavil

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amilavil

Quick Facts

Property Description
Active ingredient Amitriptyline
Form Film-coated tablets (Oral)
Pharmacological class Tricyclic Antidepressant (TCA)
Common use Mood stabilization in depressive illness
Origin Synthetic

What is Amilavil and Its Chemical Identity?

Amilavil is a prescription-only, synthetic medicinal product identified by its sole active ingredient, Amitriptyline. As a single-product formulation, Amilavil is delivered as an oral preparation, most commonly in the form of film-coated tablets. The use of a film coating is a differentiating feature designed to aid in the ease of swallowing. Amitriptyline is typically formulated as the hydrochloride salt, a form that supports its chemical identity for medicinal use.

Amilavil's Classification: The Tricyclic Antidepressant (TCA)

Amilavil is formally classified as a Tricyclic Antidepressant (TCA), positioning it within a recognized category of psychotropic agents used for various mood conditions. This structural classification (TCA) defines the medicine as distinct from newer classes of antidepressants, indicating its foundational role in the treatment of affective disorders. The significance of Amitriptyline is globally recognized, as the active substance has been included in the Model List of Essential Medicines for depressive disorders since 1977. This long-standing clinical use confirms its established value as a therapeutic option.

General Function and Purpose of Amitriptyline

The general function of Amilavil is to help restore chemical balance in the central nervous system, serving the purpose of supporting mood stability in individuals experiencing conditions such as a depressive illness. This effect is achieved through the primary high-level action of reuptake inhibition, which influences the effective concentrations of the key brain messengers serotonin and norepinephrine. The medicine’s role is to provide pharmacological support that targets the chemical components of these conditions, aiming for improved emotional regulation. This foundational mechanism is clinically recognized for its effectiveness in stabilizing mood where chemical imbalance is a factor.

Regulatory References

  1. World Health Organization’s Model List of Essential Medicines
  2. NIH

What side effects are possible with Amilavil?

Possible Side Effects and Safety Information

The safety profile of Amilavil is established through regulatory data, organizing risks into frequency-based categories and serious warnings.

Serious Safety Risks and Contraindications

Official regulatory labeling includes a Boxed Warning regarding the increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (up to age 24). This risk is recognized to persist until significant clinical improvement is achieved.

Contraindications (absolute restrictions) include the simultaneous use of Amilavil with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of severe reactions, including Serotonin Syndrome. It is also contraindicated during the acute recovery phase immediately following a myocardial infarction (heart attack).

Common and Clinically Significant Adverse Reactions

Adverse reactions are classified by frequency and the organ system affected. Reactions commonly reported in official documents include anticholinergic effects such as dry mouth, blurred vision, and constipation. Nervous system effects such as dizziness, drowsiness, and headache are also frequently documented.

Clinically significant effects classified as uncommon or rare but serious include:

  • Cardiovascular: Changes to the heart’s electrical activity (e.g., QT prolongation, arrhythmias), postural hypotension, and Tachycardia.
  • Psychiatric: Confusion, delirium, or activation of psychosis.
  • Other Serious Events: Seizures, blood dyscrasias, and increased intraocular pressure (risk of angle-closure glaucoma).

Population and Exposure-Related Considerations

Specific caution is advised for elderly patients, who are at an increased risk for certain adverse effects, including confusion, postural hypotension, and falls. Reduced starting doses are often necessary in this group. Regulatory data also emphasize the high potential for severe toxicity and life-threatening events, such as cardiac arrhythmias and convulsions, in cases of overdose, particularly with doses above 750 mg in adults.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes Amilavil (Amitriptyline) overdose as a life-threatening medical emergency primarily associated with profound toxicity to the Central Nervous System (CNS) and Cardiovascular System. All suspected overdoses, particularly those involving ingestion of 750 mg or more in adults or any dose in children, require immediate professional medical attention.

Documented Overdose Manifestations and Severe Outcomes

System Documented Clinical Signs in Overdose (Regulatory Sources)
Cardiovascular Irregular heart rate (arrhythmias), rapid heartbeat (sinus tachycardia), severe low blood pressure (hypotension), and cardiac conduction defects, including QRS widening. Fatal outcomes, such as ventricular fibrillation and cardiac arrest, are possible.
CNS/Neurological Confusion, agitation, stupor, hallucinations, muscle rigidity, seizures, and the progression to coma. Respiratory depression is a documented severe outcome.
Autonomic Dilated pupils (mydriasis), dry mouth, urinary retention, and altered body temperature control (hyperpyrexia or hypothermia).

Required Emergency Actions and Management

An overdose is considered a critical medical event. Immediate medical help must be sought by contacting emergency services or a poison control center immediately. Hospitalization for close surveillance is mandated by regulatory guidance.

There is no specific antidote known for this toxicity. Management is defined as symptomatic and supportive, and typically includes continuous Electrocardiogram (ECG) monitoring for at least 6 hours, even in asymptomatic patients, to monitor for delayed cardiac instability. Regulatory guidance also describes supportive measures such as gastrointestinal decontamination with activated charcoal and the use of intravenous sodium bicarbonate for specific cardiac effects.

Therapeutic Uses of Amilavil

Main Uses and Therapeutic Benefits of Amilavil

Amilavil (Amitriptyline) is a prescription medicine generally applied to provide pharmacological support across several distinct clinical domains characterized by persistent or recurrent symptoms. The medication is considered relevant for easing symptoms related to specific nerve discomfort and mood disturbances. It is generally applied in contexts where additional symptomatic support is needed to improve patient stability.

Therapeutic Domains

The medicine is commonly used to help with conditions such as Major Depressive Disorder (MDD), chronic neuropathic pain, and the prophylactic prevention of recurrent headaches and migraines. In these situations, Amilavil is relevant for managing symptom clusters that may become intense or disruptive. For patients experiencing chronic nerve discomfort, this application helps reduce the intensity of persistent pain signals, contributing to improved comfort. For affective disorders, it supports the patient during difficult episodes by easing distress and assists with maintaining functional stability when symptoms are more noticeable.

Quick Fact: Relief for Persistent Discomfort
Amilavil supports the management of persistent symptoms, particularly neuropathic sensations (like burning or shooting pain) and the emotional distress linked to depressive illness.

Regulatory References

  1. NIH MedlinePlus guidance on Amitriptyline

Eligibility and Restrictions for Use

Population Eligibility and Restrictions

Amilavil use is strictly defined by official regulatory rules that categorize who is eligible to use the medicine and who is absolutely prohibited.

Absolute Contraindications

Use is strictly forbidden for patients in the acute recovery phase following a myocardial infarction (MI), those with severe liver impairment, or pre-existing cardiac conditions such as heart block or certain disorders of cardiac rhythm. The medicine must also not be used by anyone with a documented hypersensitivity to the formulation, or concurrently with Monoamine Oxidase Inhibitors (MAOIs). Additionally, the medicine is contraindicated for all uses in children under 6 years of age.

Age and Life Stage Restrictions

For children and adolescents under 18 years, the medicine is not recommended for major uses, as long-term safety and efficacy are not established. Use in older adults (65 years and over) requires caution and close supervision. During pregnancy and lactation, use is not recommended unless a clear potential benefit is determined, as the drug is excreted into breast milk.

Conditional Use

Eligibility requires caution and supervision for patients with comorbidities such as a history of seizures/convulsive disorders, angle-closure glaucoma, or urinary retention. Patients with renal impairment can typically use the medicine at standard doses.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Amilavil’s (Amitriptyline) interaction profile is defined by pharmacokinetic changes and additive pharmacodynamic effects as documented in regulatory labeling. The co-administration with certain products is officially restricted or contraindicated.

Contraindicated Combinations and Timing Rules

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated due to the officially documented risk of severe Serotonin Syndrome. A mandatory 14-day wash-out period must elapse when switching between Amilavil and MAOI therapy. The combination with Cisapride is also contraindicated due to the potential for QTc prolongation and elevated risk of cardiac arrhythmia.

Pharmacokinetic and Pharmacodynamic Interactions

Pharmacokinetic interaction is documented with inhibitors of the CYP450 enzymes CYP2D6 and CYP2C19 (e.g., Fluoxetine, Paroxetine). Co-administration with these substances can lead to significantly higher plasma concentrations of Amilavil. Furthermore, Amilavil may enhance the response to alcohol and other CNS depressants (e.g., sedatives), leading to an officially noted additive CNS depression effect. Using Amilavil with other serotonergic agents (including the herbal product St. John’s Wort) increases the risk of Serotonin Syndrome. Caution is also noted for elderly patients, who may face a greater risk of interaction outcomes such as hyponatremia.

Mechanism of Action

How Amilavil Works

The core of Amilavil's action is its ability to influence several neurotransmitter systems simultaneously, driven by two distinct mechanistic principles: the sustained regulation of monoamines and the immediate blockade of multiple receptor types.


Dual Reuptake Inhibition and Neurotransmitter Potentiation

The drug's primary action is the non-selective inhibition of the Norepinephrine (NET) and Serotonin (SERT) transporter proteins. By blocking these transporters, Amilavil prevents the rapid clearance of these key messengers from the synaptic space, leading to their prolonged activity. This initial molecular step triggers a slow, adaptive cascade where the prolonged signaling gradually recalibrates the sensitivity and function of post-synaptic receptors, which ultimately contributes to the physiological modulation of central nervous system pathways.


Non-Monoamine Receptor Antagonism

Amilavil also engages in direct antagonism by binding to and blocking several non-monoamine receptors, most notably the central Histamine H1 and Muscarinic cholinergic receptors. These interactions occur immediately upon the drug reaching the central nervous system, producing rapid physiological consequences. The blockade of H1 receptors results in the suppression of signaling associated with alertness and central nervous system depression, while Muscarinic receptor antagonism affects the regulation of the autonomic nervous system.

Dosage and Administration Information

Amilavil (amitriptyline hydrochloride) is a medication that must be taken exactly as prescribed by your healthcare provider. The dosing regimen will vary based on the treated condition, the patient's age, and their response to treatment.

General Administration Guidelines

Guideline Instruction
Dosing Schedule Due to its sedative properties, Amilavil is typically taken as a single daily dose at bedtime. Your doctor may adjust this schedule based on your individual needs.
Administration The tablet should be swallowed whole with a glass of water. Do not crush, break, or chew the tablet, as this may release the medication too quickly and affect its action.
Food Interaction Amilavil may be taken with or without food.
Missed Dose If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not take a double dose to compensate for a missed one.

Important Considerations

Treatment is generally initiated with a low dose and gradually increased (titrated) to find the minimum effective dose, which helps reduce the risk of side effects. It may take several weeks to observe the full therapeutic effect. Do not suddenly stop taking this medication without consulting your doctor, as abrupt discontinuation can lead to withdrawal symptoms.

Recent Clinical Evidence

Research evidence / Overview of studies

This section outlines the research that examined the combination drug therapy in patients with severe, chronic condition Y.


Key Efficacy Findings

A major study reported findings that the drug combination was associated with a reduction in symptom intensity compared to placebo. The study noted that tolerability findings were reported.

Another randomized controlled trial (RCT) evaluated whether the drug combination was associated with reduced pain and improved sleep quality in participants. Researchers in the study reported findings from a comparison to the current standard of care for this patient group, showing different results.


Dosage and Administration

The research exploring this combination therapy focused on a specific low-dose regimen. The trial protocol included administration timing. The research further explored findings related to pain.


Safety and Tolerability Profile

Research evaluated this combination therapy in the context of condition Y; studies examined the reported results, including data related to other medications.

Long-term safety studies evaluated the tolerability data. However, some studies indicated that participants with a known history of heart problems were excluded from the drug combination trials, suggesting limitations on the generalization of safety findings to that population.

Frequently Asked Questions (FAQ)

Common questions about Amilavil (FAQ)

Q: Is feeling more tired than usual a common side effect of Amilavil?

According to official product information, drowsiness and a feeling of tiredness are frequently reported side effects when taking Amilavil. This effect may decrease over time as the body adjusts to the medication. If drowsiness is persistent or severe, individuals should consider discussing this with their healthcare provider.


Q: How common are digestive issues like nausea or diarrhea with Amilavil?

Regulatory documents list gastrointestinal side effects, with constipation being a common effect due to the drug's anticholinergic properties. While nausea and diarrhea are possible, their frequency is typically less common than constipation. Persistent or troubling digestive issues may be reviewed with a healthcare provider.


Q: Can Amilavil cause changes in weight?

Yes, regulatory labeling indicates that changes in weight are a reported side effect of Amilavil. Both unexpected weight gain or loss have been noted to occur with the use of this medication. A healthcare provider can offer guidance on monitoring weight during treatment.


Q: Is Amilavil the same type of drug as [similar drug name]?

Amilavil belongs to a recognized category of medications called Tricyclic Antidepressants (TCAs). This classification reflects its chemical structure and the way it works in the body. Although it may treat conditions similar to other drugs, the TCA classification defines its distinct pharmacological profile.


Q: What makes Amilavil different from other medicines that treat the same condition?

Amilavil has a unique mechanism of action that involves two primary steps. It inhibits the reuptake of both serotonin and norepinephrine, and also directly blocks central histamine and muscarinic receptors. This dual activity profile contributes to its broad effects, including its known sedative properties.


Q: Is Amilavil known to cause dizziness or lightheadedness?

Yes, official safety information frequently documents dizziness as a side effect. The drug can also cause postural hypotension (a drop in blood pressure when standing up), which may lead to feelings of lightheadedness. Individuals who experience these effects are often advised to use caution when changing positions, particularly when moving from sitting or lying down.


Q: Why does Amilavil have the potential for certain side effects?

The side effects of Amilavil are related to its mechanism of action. The drug works by blocking multiple receptors in the central nervous system, including histamine and muscarinic cholinergic receptors. For example, blocking the histamine receptors contributes to the feeling of drowsiness, while blocking muscarinic receptors can cause anticholinergic effects like dry mouth and constipation.


Q: Are there any major diet restrictions when taking Amilavil?

Official product information states that Amilavil can be taken with or without food. However, it is explicitly noted that this medication may enhance the response to alcohol, leading to an increased risk of additive central nervous system (CNS) depression. Official information advises caution regarding alcohol consumption.


Q: Are there any vitamins or supplements that interact with Amilavil?

Yes, official documents indicate that Amilavil should not be taken with certain supplements. Specifically, combining Amilavil with other serotonergic agents, including the herbal product St. John’s Wort, is noted to increase the risk of a serious reaction known as Serotonin Syndrome.


Q: Does Amilavil interact with cold and flu medications?

Regulatory labeling cautions that Amilavil may have an additive CNS depressant effect when combined with other central nervous system (CNS) depressants. Since many over-the-counter cold and flu medications contain ingredients with CNS depressant properties, consulting with a healthcare professional or pharmacist can help confirm compatibility.


Q: What are the signs of a serious reaction to Amilavil I should watch for?

Serious reactions that require attention include signs of Serotonin Syndrome (such as agitation, rapid heartbeat, or hallucinations), allergic reactions (like swelling of the face or throat, or trouble breathing), and certain cardiovascular issues (like a significant change in heart rhythm or fainting). If symptoms of a serious reaction are experienced, immediate medical attention, such as contacting emergency services or a doctor, is necessary.


Q: How do I know if Amilavil is working for me?

Studies and official information indicate that the full therapeutic effect of Amilavil may take several weeks to observe. The expected outcome includes support for mood stability and a reduction in symptom intensity. Symptoms like anxiety and sleep trouble are sometimes reported to respond within the first week.


Q: What is the expected outcome of treatment with Amilavil?

The general function of Amilavil is to help restore chemical balance in the brain to support mood stability and improved emotional regulation in individuals with depressive illness. Research studies have also noted that the medication is associated with a reduction in symptom intensity.


Q: How quickly does Amilavil start working after taking it?

Although the full therapeutic effect takes several weeks to become noticeable, official labeling indicates that some symptoms, such as trouble sleeping, feelings of guilt, and anxiety, may begin to show a response within the first week of treatment. Improvements in mood may follow later.


Q: How long do the effects of Amilavil last?

Amilavil is typically prescribed to be taken once daily, usually at bedtime, due to its sedative properties. For conditions where it is used to manage pain or symptoms, official information indicates that treatment is symptomatic and is continued for an appropriate length of time.


Q: What happens if you suddenly stop taking Amilavil?

Official information strongly advises against suddenly stopping Amilavil without the guidance of a healthcare provider. Abrupt discontinuation can lead to withdrawal symptoms (known as discontinuation syndrome). These symptoms may include headache, nausea, trouble sleeping, depression, mood swings, and flu-like symptoms.


Q: Is it normal to have mild headaches when first starting Amilavil?

Yes, headache is listed in product information as one of the commonly reported side effects when initiating this medication. If the headaches are mild, they may resolve within a few days or weeks as the body adjusts to the treatment.


Q: Does Amilavil affect blood sugar levels?

Official information indicates that Amilavil can potentially make it more difficult to keep your blood sugar stable, potentially causing an increase or decrease. Individuals monitoring blood sugar may want to discuss this potential effect with their doctor.


Q: Can I drive or operate machinery while on Amilavil?

Due to the potential for Amilavil to cause drowsiness, dizziness, or blurred vision, official safety guidelines recommend that individuals avoid driving or operating hazardous machinery until they are aware of how Amilavil affects them.


Q: Can Amilavil affect mood or anxiety?

Amilavil is used to support mood stability. However, the regulatory Boxed Warning notes an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults. Patients are also advised to watch for new or increased feelings of anxiety, agitation, irritability, or other unusual changes in mood or behavior.


Q: Is Amilavil safe for people with liver disease?

Regulatory documents state that severe liver impairment is an absolute contraindication for using Amilavil. In cases of non-severe impaired liver function, the medication is typically used with caution and close supervision.


Q: What should I do if I experience a persistent side effect from Amilavil?

If you experience any side effects that are severe, bothersome, or do not go away after a few days or weeks of treatment, a review with a doctor or pharmacist is advised. They can provide guidance on managing the effect or whether a change in treatment is necessary.


Q: How often should I follow up with my doctor while taking Amilavil?

Official medication guides stress that a doctor should check your progress at regular visits. These follow-up visits allow for careful monitoring and potential dose adjustments. Keeping all scheduled appointments is generally emphasized in medication guides.


Q: Are there any long-term health risks associated with Amilavil?

Long-term use is associated with the need for careful monitoring, particularly due to the Boxed Warning regarding the risk of suicidal thoughts and behaviors in younger adults. Additionally, the drug has the potential to cause serious cardiovascular effects, such as changes to the heart's rhythm, which may be a long-term risk and require regular medical supervision.


Q: Does Amilavil cause photosensitivity (increased sensitivity to the sun)?

Official information confirms that Amilavil can cause photosensitivity, meaning it can make your skin more sensitive to light from the sun, sunlamps, and tanning beds. Individuals using this medication are generally advised to take appropriate measures to protect their skin from UV exposure.


Q: Does Amilavil affect sleep patterns?

Yes, Amilavil is known to have marked sedative properties, which is why it is often taken at bedtime. Regulatory studies have also indicated that it may affect the overall structure of sleep, such as changing the proportion of time spent in different sleep stages.


Q: Is it common to need a dose adjustment after starting Amilavil?

Yes, the standard approach to starting Amilavil is to begin with a low dose and gradually increase (titrate) it over time. This process is intended to find the minimum dose that is effective for the individual. Regular follow-up visits are important for monitoring and potential dose adjustments.


Q: Can I take herbal teas while on Amilavil?

While specific herbal teas are not explicitly listed in interaction warnings, regulatory documents caution against taking Amilavil with certain herbal products like St. John's Wort, due to the risk of severe interaction. It is generally recommended to consult with a healthcare professional before consuming herbal teas or other herbal products while on this medication.

How should Amilavil be stored and disposed of?

How to Store and Dispose of Amilavil?

The storage and disposal of Amilavil (Amitriptyline hydrochloride tablets) must adhere strictly to the conditions required by regulatory labeling to ensure product quality and safety.

Storage Requirements

The medicine must be stored at Controlled Room Temperature, specifically between 20 C to 25 C (68 F to 77 F). The dispensing container must be tight and light-resistant to protect the tablets from environmental factors. For child safety, the medicine must be kept out of the reach of children and stored locked up.

Disposal Requirements

Unused or expired Amilavil must be disposed of through an appropriate treatment and disposal facility. Disposal must always be completed in accordance with applicable laws and regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amilavil found in:

A-Z Index: